Xuewen Song

3.0k total citations · 1 hit paper
39 papers, 1.9k citations indexed

About

Xuewen Song is a scholar working on Genetics, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Xuewen Song has authored 39 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Genetics, 24 papers in Molecular Biology and 8 papers in Pathology and Forensic Medicine. Recurrent topics in Xuewen Song's work include Genetic and Kidney Cyst Diseases (28 papers), Renal and related cancers (18 papers) and Genetic Syndromes and Imprinting (13 papers). Xuewen Song is often cited by papers focused on Genetic and Kidney Cyst Diseases (28 papers), Renal and related cancers (18 papers) and Genetic Syndromes and Imprinting (13 papers). Xuewen Song collaborates with scholars based in Canada, United States and China. Xuewen Song's co-authors include York Pei, Amirreza Haghighi, Matthew B. Lanktree, Feng Qian, Norman D. Rosenblum, Valeria Di Giovanni, Kairong Wang, Ning He, Andrew D. Paterson and Alistair J. Ingram and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and Nature Materials.

In The Last Decade

Xuewen Song

39 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Defective glucose metabolism in polycystic kidney disease identifies a new therapeutic strategy

2013 384 citations Isaline Rowe, Marco Chiaravalli et al. Nature Medicine profile →

Peers

Countries citing papers authored by Xuewen Song

Since Specialization

Citations

This map shows the geographic impact of Xuewen Song's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuewen Song with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuewen Song more than expected).

Fields of papers citing papers by Xuewen Song

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuewen Song. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuewen Song. The network helps show where Xuewen Song may publish in the future.

Co-authorship network of co-authors of Xuewen Song

This figure shows the co-authorship network connecting the top 25 collaborators of Xuewen Song. A scholar is included among the top collaborators of Xuewen Song based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuewen Song. Xuewen Song is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Patients With Mild ADPKD by Kidney Imaging but Low Estimated GFR 2025 ·Kidney International Reports ·(unknown), Maren Cam, (unknown), (unknown), (unknown), Amirreza Haghighi, Xuewen Song, Korosh Khalili, York Pei	1
2	Magnetic fly ash@carbon microspheres for high-performance electromagnetic wave absorption 2023 ·Ceramics International ·Hongjie Gao, Xiaomin Zhang, (unknown), Jie Yu, Shuang Yang, (unknown), Tianxing Chen, Panyang He, (unknown), Xuewen Song	13
3	Preclinical evaluation of tolvaptan and salsalate combination therapy in a Pkd1-mouse model 2023 ·Frontiers in Molecular Biosciences ·Xuewen Song, Wouter N. Leonhard, (unknown), Gregory R. Steinberg, York Pei, Dorien J.M. Peters	5
4	Urinary epidermal growth factor/monocyte chemotactic peptide 1 ratio as non-invasive predictor of Mayo clinic imaging classes in autosomal dominant polycystic kidney disease 2022 ·Journal of Nephrology ·Maria Teresa Rocchetti, Francesco Pesce, (unknown), (unknown), Ighli di Bari, Francesco Trepiccione, Giovanna Capolongo, (unknown), Xuewen Song, (unknown), Amirreza Haghighi, Dorien J.M. Peters, (unknown), Paola Pontrelli, Giuseppe Stefano Netti, Elena Ranieri, Giovambattista Capasso, Marco Moschetta, York Pei, Loreto Gesualdo, (unknown)	1
5	Patients with Protein-Truncating PKD1 Mutations and Mild ADPKD 2021 ·Clinical Journal of the American Society of Nephrology ·Matthew B. Lanktree, Elsa Guiard, (unknown), Marina Pourafkari, Ioan-Andrei Iliuta, Syed Ishtiaque Ahmed, Amirreza Haghighi, Ning He, Xuewen Song, Andrew D. Paterson, Korosh Khalili, York Pei	19
6	Global microRNA profiling in human urinary exosomes reveals novel disease biomarkers and cellular pathways for autosomal dominant polycystic kidney disease 2020 ·Kidney International ·(unknown), Xuewen Song, Andrew J. Streets, (unknown), (unknown), Manoj K. Valluru, (unknown), (unknown), Amirreza Haghighi, Roslyn Simms, Frederick W.K. Tam, York Pei, Albert Ong	48
7	Targeting AMP-activated protein kinase (AMPK) for treatment of autosomal dominant polycystic kidney disease 2020 ·Cellular Signalling ·Xuewen Song, (unknown), Gregory R. Steinberg, York Pei	26
8	Connectivity mapping of a chronic kidney disease progression signature identified lysine deacetylases as novel therapeutic targets 2020 ·Kidney International ·Vanessa Williams, Ana Konvalinka, Xuewen Song, Xiao‐Hua Zhou, Rohan John, York Pei, James W. Scholey	22
9	Insights into Autosomal Dominant Polycystic Kidney Disease from Genetic Studies 2020 ·Clinical Journal of the American Society of Nephrology ·Matthew B. Lanktree, Amirreza Haghighi, Ighli di Bari, Xuewen Song, York Pei	80
10	Prevalence Estimates of Polycystic Kidney and Liver Disease by Population Sequencing 2018 ·Journal of the American Society of Nephrology ·Matthew B. Lanktree, Amirreza Haghighi, Elsa Guiard, (unknown), Xuewen Song, Peter C. Harris, Andrew D. Paterson, York Pei	181
11	A RhoA–YAP–c-Myc signaling axis promotes the development of polycystic kidney disease 2018 ·Genes & Development ·Jing Cai, Xuewen Song, Wei Wang, Terry Watnick, York Pei, Feng Qian, Duojia Pan	95
12	Murine recombinant angiotensin-converting enzyme 2 attenuates kidney injury in experimental Alport syndrome 2017 ·Kidney International ·Eun Hui Bae, Fei Fang, Vanessa Williams, Ana Konvalinka, Xiao‐Hua Zhou, Vaibhav B. Patel, Xuewen Song, Rohan John, Gavin Y. Oudit, York Pei, James W. Scholey	36
13	Organoid cystogenesis reveals a critical role of microenvironment in human polycystic kidney disease 2017 ·Nature Materials ·Nelly M. Cruz, Xuewen Song, Stefan Czerniecki, Ramila E. Gulieva, Angela J. Churchill, Yong Kyun Kim, (unknown), Linh M. Tran, (unknown), Hongxia Fu, Laura S. Finn, York Pei, Jonathan Himmelfarb, Benjamin Freedman	218
14	Quantification of angiotensin II-regulated proteins in urine of patients with polycystic and other chronic kidney diseases by selected reaction monitoring 2016 ·Clinical Proteomics ·Ana Konvalinka, Ihor Batruch, Tomáš Tokár, Apostolos Dimitromanolakis, (unknown), Xuewen Song, York Pei, Andrei P. Drabovich, Eleftherios P. Diamandis, Igor Jurišica, James W. Scholey	20
15	Characterization of the Intrarenal Renin-Angiotensin System in Experimental Alport Syndrome 2015 ·American Journal Of Pathology ·Eun Hui Bae, Ana Konvalinka, Fei Fang, Xiao‐Hua Zhou, Vanessa Williams, (unknown), Xuewen Song, Shao‐Ling Zhang, Rohan John, Gavin Y. Oudit, York Pei, James W. Scholey	27
16	The Cleaved Cytoplasmic Tail of Polycystin-1 Regulates Src-Dependent STAT3 Activation 2014 ·Journal of the American Society of Nephrology ·(unknown), Xuewen Song, Xiaofang Wang, Markus M. Rinschen, Nicholas Doerr, Wells B. LaRivière, Bernhard Schermer, York Pei, Vicente E. Torres, Thomas Weimbs	53
17	Defective glucose metabolism in polycystic kidney disease identifies a new therapeutic strategy breakdown → 2013 ·Nature Medicine ·Isaline Rowe, Marco Chiaravalli, Valeria Mannella, (unknown), Giacomo Quilici, Monika Pema, Xuewen Song, Hangxue Xu, Silvia Mari, Feng Qian, York Pei, Giovanna Musco, Alessandra Boletta	384
18	Evidence for Pathogenicity of Atypical Splice Mutations in Autosomal Dominant Polycystic Kidney Disease 2009 ·Clinical Journal of the American Society of Nephrology ·(unknown), (unknown), (unknown), Onur Çil, Ning He, Xuewen Song, Andrew D. Paterson, York Pei	12
19	Systems biology of autosomal dominant polycystic kidney disease (ADPKD): computational identification of gene expression pathways and integrated regulatory networks 2009 ·Human Molecular Genetics ·Xuewen Song, Valeria Di Giovanni, Ning He, Kairong Wang, Alistair J. Ingram, Norman D. Rosenblum, York Pei	195
20	Polycystin-1 C-terminal tail associates with β-catenin and inhibits canonical Wnt signaling 2008 ·Human Molecular Genetics ·Mark Lal, Xuewen Song, Jennifer L. Pluznick, Valeria Di Giovanni, David Merrick, Norman D. Rosenblum, Véronique Chauvet, Cara J. Gottardi, York Pei, Michael J. Caplan	142

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact